744 Results (Page 7 of 30)
Medical Devices Markets Research Reports
Nigeria ENT Devices Market Analysis
The Nigeria ENT Devices Market is projected to grow from $20 Mn in 2022 to $40 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Nigeria ENT devices market include Medlog Healthcare Solutions, Healthplus Limited, and Nemaura Medical.
UAE Contraceptive Devices Market Analysis
The UAE Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $129 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-2030. In the UAE, particularly among young people, there is a high frequency of STDs. Because of this, there is an increased need for barrier methods of contraception like condoms, which is boosting the market for contraceptive manufacturers. The market is segmented by type and by gender. Some key players in this market include Julphar Life, Neopharma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
Turkey Contraceptive Devices Market Analysis
The Turkey Contraceptive Devices Market is expected to witness growth from $103 Mn in 2022 to $198 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-2030. The proportion of women working in Turkey has been rising significantly in recent years. As women balance their jobs with family planning and childrearing, this has led to a larger need for family planning and contraception. The market is segmented by type and by gender. Some key players in this market include Tubitak Marmara, Acibadem Labmed, Megasan Medikal, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
Tanzania Contraceptive Devices Market Analysis
The Tanzania Contraceptive Devices Market is expected to witness growth from $5 Mn in 2022 to $10 Mn in 2030 with a CAGR of 8.90% for the forecasted year 2022-2030. In Tanzania, there is a rising awareness of and need for family planning, spurred by the need to enhance social and economic conditions, mother and child health outcomes, and other aspects. As a result, there is now a higher need for contraceptive methods, which presents growth potential for manufacturers. The market is segmented by type and by gender. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
Mexico ENT Devices Market Analysis
The Mexico ENT Devices Market is projected to grow from $350 Mn in 2022 to $550 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Mexico ENT devices market include ACI Medical, Gamma Medical Instruments, and LAB-MED.
Malaysia ENT Devices Market Analysis
The Malaysia ENT Devices Market is projected to grow from $40 Mn in 2022 to $60 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Malaysia ENT devices market include Meditop, Meditrade, and ENTtech Medical Solutions.
Kenya ENT Devices Market Analysis
The Kenya ENT Devices Market is projected to grow from $20 Mn in 2022 to $30 Mn by 2030, registering a CAGR of 6.9% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Kenya ENT devices market include Phoenix Equipment, Toda Medical Supplies, and Megascope Healthcare.
Japan ENT Devices Market Analysis
The Japan ENT Devices Market is projected to grow from $1.44 Bn in 2022 to $2.34 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Japan ENT devices market include Olympus Corporation, Fukuda Denshi, and HOYA Corporation.
Italy ENT Devices Market Analysis
The Italy ENT Devices Market is projected to grow from $560 Mn in 2022 to $840 Mn by 2030, registering a CAGR of 5.3% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Italy ENT devices market include Medtronic Italia, Grandi, and Moria.
Indonesia ENT Devices Market Analysis
The Indonesia ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Indonesia ENT devices market include Innonovatech Medica, Dharma Intisemesta, and Bina Medika Lestari.
India ENT Devices Market Analysis
The India ENT Devices Market is projected to grow from $420 Mn in 2022 to $820 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022 - 2030. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the India ENT devices market include Phoenix Medical Systems, Surgitech Innovations, and Zephyr Surgicals.
UK Contraceptive Devices Market Analysis
The UK Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-2030. In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilise contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. The market is segmented by type and by gender. Some key players in this market include Consilient Health, Renovos Biologics, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
Vietnam Coronary Stents Market Analysis
The Vietnam Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $83 Mn in 2030 with a CAGR of 4.98% for the forecasted year 2022-2030. A growing number of foreign patients seeking reasonably priced medical treatments, such as coronary stenting, are choosing Vietnam as their destination of choice for medical tourism. The market for coronary stents is anticipated to rise as a result of more medical institutions increasing their product offerings to meet the needs of this market. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Vinamed, VietMedical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
UAE Coronary Stents Market Analysis
The UAE Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. In the UAE, the prevalence of coronary artery disease is increasing as a result of factors such as poor diet, smoking, and rising obesity rates. As a result, the need for coronary stents to treat the condition is rising. The market is segmented by type and by gender. Some key players in this market include Neopharma, Emirates Biotech Pharmaceutical, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Turkey Coronary Stents Market Analysis
The Turkey Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who make an investment in educational programmes to spread the word about the advantages of coronary stents may be able to enhance their market share. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Thailand Coronary Stents Market Analysis
The Thailand Coronary Stents Market is expected to witness growth from $14 Mn in 2022 to $20 Mn in 2030 with a CAGR of 5.09% for the forecasted year 2022-2030. One of the main factors propelling market expansion in Thailand is the increasing incidence and prevalence of coronary artery disease. Demand for coronary stents and related goods is projected to rise as more patients are given a diagnosis of coronary artery disease. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Xovic, Meticuly, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Spain Coronary Stents Market Analysis
The Spain Coronary Stents Market is expected to witness growth from $218 Mn in 2022 to $293 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-2030. In Spain, procedures involving coronary stents are minimally invasive, which may lead to shorter hospital stays, quicker recoveries, and lower healthcare expenses. As a result, Spain is seeing an increase in the use of minimally invasive techniques, which is fueling the need for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Medlumics, Devicare, Ekuore, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
South Korea Coronary Stents Market Analysis
The South Korea Coronary Stents Market is expected to witness growth from $165 Mn in 2022 to $258 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. In South Korea, the frequency of coronary artery illness is increasing which is anticipated to increase demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Nanoomtech, Kolon Life Science, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
South Africa Coronary Stents Market Analysis
The South Africa Coronary Stents Market is expected to witness growth from $73 Mn in 2022 to $117 Mn in 2030 with a CAGR of 5.98% for the forecasted year 2022-2030. A greater percentage of the population in South Africa is over 60 years old, signalling an ageing population. This group is more likely to have coronary artery disease, which is projected to boost demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, Tekmed, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Poland Coronary Stents Market Analysis
The Poland Coronary Stents Market is expected to witness growth from $66 Mn in 2022 to $98 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-2030. The demand for minimally invasive procedures like stenting is increasing as individuals and healthcare professionals look for less invasive treatment choices more frequently. In Poland, the demand for coronary stents is being driven by this trend. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Balton, Metrum Cryoflex, Skamex, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Philippines Coronary Stents Market Analysis
The Philippines Coronary Stents Market is expected to witness growth from $25 Mn in 2022 to $37 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. As cardiovascular disease awareness increases in the Philippines, more patients are seeking early diagnosis and treatment of CAD, which is driving up the demand for coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Medasia Medical, S.E.A. Olympus, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Nigeria Coronary Stents Market Analysis
The Nigeria Coronary Stents Market is expected to witness growth from $10 Mn in 2022 to $16 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-2030. Minimally invasive procedures like Percutaneous Coronary Intervention (PCI) are becoming more popular in Nigeria due to their shorter hospital stays, quicker recoveries, and lower costs. This is driving the need for coronary stents as a crucial component of PCI operations. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include AfricaMed, GBioMed, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, JNC International, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Malaysia Coronary Stents Market Analysis
The Malaysia Coronary Stents Market is expected to witness growth from $18 Mn in 2022 to $27 Mn in 2030 with a CAGR of 4.95% for the forecasted year 2022-2030. The introduction of coronary stents as a treatment option for CAD is being driven by a rising desire for minimally invasive procedures in Malaysia because these procedures are less invasive and have quicker recovery times than conventional surgical procedures. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Qualitas Medical Group, GA2 Medical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Kenya Coronary Stents Market Analysis
The Kenya Coronary Stents Market is expected to witness growth from $8 Mn in 2022 to $12 Mn in 2030 with a CAGR of 5.85% for the forecasted year 2022-2030. In Kenya, both the incidence and prevalence of coronary artery disease are rising. Since CAD is one of the main conditions requested for the implantation of coronary stents, this is a significant market growth driver for manufacturers of coronary stents. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Apicalmed, Asterisk, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Japan Coronary Stents Market Analysis
The Japan Coronary Stents Market is expected to witness growth from $702 Mn in 2022 to $1058 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-2030. The early identification and treatment of coronary artery disease in Japan are projected to be driven by increased access to healthcare and improved heart health awareness, opening up the potential for manufacturers in the coronary stent market. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Terumo Corporation, Fukuda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.